- Home
- Products
- Customized ADCs
- EpCAM
- Anti-EpCAM (clone B38.1)-Mal-dPEG4-NHS-DM1 ADC
Anti-EpCAM (clone B38.1)-Mal-dPEG4-NHS-DM1 ADC (CAT#: ADC-W-396)
This ADC product is comprised of an anti-EpCAM monoclonal antibody (clone B38.1) conjugated via a Mal-dPEG4-NHS linker to a DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, DM1 binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
- Product Information
- ADC Target
- ADC Antibody
- ADC Linker
- ADC payload drug
- Antibody clone #
- B38.1
- Name
- EpCAM
- Alternative Names
- EPCAM; epithelial cell adhesion molecule; ESA; KSA; M4S1; MK-1; DIAR5; EGP-2; EGP40; KS1/4; MIC18; TROP1; EGP314; HNPCC8; TACSTD1; epithelial glycoprotein 314; human epithelial glycoprotein-2; cell surface glycoprotein Trop-1; adenocarcinoma-associated an
- Target Entrez Gene ID
- 4072
- Target UniProt ID
- P16422
- Overview
- This gene encodes a carcinoma-associated antigen and is a member of a family that includes at least two type I membrane proteins. This antigen is expressed on most normal epithelial cells and gastrointestinal carcinomas and functions as a homotypic calcium-independent cell adhesion molecule. The antigen is being used as a target for immunotherapy treatment of human carcinomas. Mutations in this gene result in congenital tufting enteropathy.
- Overview
- Anti-EpCAM IgG1 Antibody, clone # B38.1
- Clone #
- B38.1
- Species Reactivity
- Human
- Name
- PEG4Mal
- Name
- DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine)
- Description
- Derived from Maytansinoid,a group of cytotoxins structurally similar to rifamycin, geldanamycin, and ansatrienin. The eponymous natural cytotoxic agent maytansine is a 19-member lactam (ansa
macrolide) structure originally isolated from the Ethiopian shrub Maytenus ovatus. Maytansinoids can bind to tubulin at or near the vinblastine-binding site, which interfere the formation of microtubules and depolymerize already formed microtubules, inducing mitotic arrest in the intoxicated cells.
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-TNC (Tenatumomab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-1818)
- Anti-TPBG (K392C)-Mc-MMAD ADC (CAT#: ADC-W-163)
- Anti-CEACAM6 (Sulesomab)-MC-MMAF ADC (CAT#: ADC-W-976)
- Anti-IL6 (Olokizumab)-SMCC-DM1 ADC (CAT#: ADC-W-1418)
- Anti-FGFR2 (clone 11725)-sulfo-SMCC-DM1 ADC (CAT#: ADC-W-064)
- Anti-CD40 (Dacetuzumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-899)
- Anti-PDGFR (Olaratumab)-MC-MMAF ADC (CAT#: ADC-W-1708)
- Anti-FOLH1-Mc-VC-PABC-MMAE ADC (CAT#: ADC-W-156)
- Anti-FcrL5 (clone 13G9)-Mc-VC-PABC-MMAE ADC (CAT#: ADC-W-501)
- Anti-ITGB3 (Tadocizumab)-SPDB-DM4 ADC (CAT#: ADC-W-2605)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-W-396. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
Same Linker
Same Payload
CAT# | Product Name | Linker | Payload |
ADC-W-1096 | Anti-EPCAM (Edrecolomab)-MC-MMAF ADC | MC (maleimidocaproyl) | MMAF |
ADC-W-1081 | Anti-EPCAM (Citatuzumab bogatox)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
ADC-W-1079 | Anti-EPCAM (Citatuzumab bogatox)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
ADC-W-1095 | Anti-EPCAM (Edrecolomab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
ADC-W-1087 | Anti-EPCAM (Tucotuzumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
CAT# | Product Name | Linker | Payload |
ADC-W-313 | Anti-MUC1 (clone huC242)-PEG4Mal-DM1 ADC | PEG4Mal | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
CAT# | Product Name | Linker | Payload |
ADC-W-572 | Anti-ERBB2 (Trastuzumab-Fab)-SPP-DM1 ADC | SPP (N-succinimidyl-4-(2-pyridyldithio)pentanoate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
ADC-W-603 | Anti-FOLH1 (clone J591)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
ADC-W-487 | Anti-CD70-MCC-DM1 ADC | MCC (Maleimidomethyl cyclohexane-1-carboxylate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
ADC-W-496 | Anti-EGFR-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
ADC-AA-050 | Protein G-MCC-DM1 ADC | MCC (Maleimidomethyl cyclohexane-1-carboxylate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.